MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $211,000 | +1.0% | 4,895 | -12.1% | 0.00% | 0.0% |
| Q3 2015 | $209,000 | -55.3% | 5,571 | -59.5% | 0.00% | -66.7% |
| Q2 2015 | $468,000 | +51.0% | 13,752 | +57.4% | 0.00% | +50.0% |
| Q1 2015 | $310,000 | +5.4% | 8,739 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $294,000 | -28.6% | 8,638 | -18.9% | 0.00% | -33.3% |
| Q3 2014 | $412,000 | +10200.0% | 10,649 | +10549.0% | 0.00% | – |
| Q2 2014 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | 0.0% | 100 | -20.0% | 0.00% | – |
| Q4 2013 | $3,000 | -97.5% | 125 | -97.5% | 0.00% | -100.0% |
| Q3 2013 | $119,000 | +3866.7% | 5,045 | +3936.0% | 0.01% | – |
| Q2 2013 | $3,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |